Funding for this research was provided by:
U.S. Department of Defense (W81XWH-20-10353)
Patrick C. Walsh Prostate Cancer Research Fund
Prostate Cancer Foundation
National Cancer Institute (U54CA143803, CA163124, CA093900, CA143055)
William and Carolyn Stutt Research Fund
MC Dean, Inc.
William and Marjorie Springer
Mary and Dave Stevens
Louis Dorfman
Jones Family Foundation
Ronald Rose
Article History
Received: 1 September 2021
Accepted: 12 September 2021
First Online: 28 September 2021
Declarations
:
: KP discloses that he is a consultant to Cue Biopharma, Inc., an equity holder in PEEL therapeutics, and a founder and equity holder in Keystone Biopharma, Inc. SA discloses that she is an equity holder in Keystone Biopharma, Inc.
: Not applicable.
: Not applicable.
: All authors consent to the publication of this manuscript.